Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2017, Article ID 2371956, 6 pages
https://doi.org/10.1155/2017/2371956
Research Article

Renal Dysfunction Is an Independent Risk Factor for Poor Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A New Cutoff Value

1Department of Neurology, Neurocritical Care, Cerebrovascular Disease, Eskisehir Osmangazi University, Eskisehir, Turkey
2Department of Neurology, Neuroscience Research Center (NSRC), Imam-Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
3Department of Neurology, Cerebrovascular Disease, Eskisehir Osmangazi University, Eskisehir, Turkey
4Department of Biostatistics, Eskisehir Osmangazi University, Eskisehir, Turkey

Correspondence should be addressed to Elyar Sadeghi-Hokmabadi; moc.oohay@ssaea

Received 23 July 2016; Revised 3 December 2016; Accepted 14 December 2016; Published 3 January 2017

Academic Editor: Wai-Kwong Tang

Copyright © 2017 Elyar Sadeghi-Hokmabadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. Lees, E. Bluhmki, R. von Kummer et al., “Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials,” The Lancet, vol. 375, no. 9727, pp. 1695–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Lee, J. L. Saver, K.-H. Chang, H.-W. Liao, S.-C. Chang, and B. Ovbiagele, “Low glomerular filtration rate and risk of stroke: meta-analysis,” British Medical Journal, vol. 341, Article ID c4249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Mostofsky, G. A. Wellenius, A. Noheria et al., “Renal function predicts survival in patients with acute ischemic stroke,” Cerebrovascular Diseases, vol. 28, no. 1, pp. 88–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Tsagalis, T. Akrivos, M. Alevizaki et al., “Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality,” Nephrology Dialysis Transplantation, vol. 24, no. 1, pp. 194–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. A. Lyrer, F. Fluri, D. Gisler, S. Papa, F. Hatz, and S. T. Engelter, “Renal function and outcome among stroke patients treated with IV thrombolysis,” Neurology, vol. 71, no. 19, pp. 1548–1550, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. T. Lo, C. Y. Cheung, C. K. Li, K. F. Chau, and W. C. Fong, “Thrombolysis in Chinese ischemic stroke patients with renal dysfunction,” Interventional Neurology, vol. 3, no. 2, pp. 101–106, 2014. View at Publisher · View at Google Scholar
  7. A. Power, D. Epstein, D. Cohen et al., “Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke,” Cerebrovascular Diseases, vol. 35, no. 1, pp. 45–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Agrawal, B. Rai, J. Fellows, and P. A. McCullough, “In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke,” Nephrology Dialysis Transplantation, vol. 25, no. 4, pp. 1150–1157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Sobolewski, G. Kozera, R. Kaźmierski et al., “Intravenous rt-PA in patients with ischaemic stroke and renal dysfunction,” Clinical Neurology and Neurosurgery, vol. 115, no. 9, pp. 1770–1774, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. T.-H. Chao, T.-C. Lin, Y. Shieh et al., “Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction,” European Neurology, vol. 70, no. 5-6, pp. 316–321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Hsieh, H. Lin, S. Sung, H. Hsieh, E. C. Lai, and C. Chen, “Is renal dysfunction associated with adverse stroke outcome after thrombolytic therapy,” Cerebrovascular Diseases, vol. 37, no. 1, pp. 51–56, 2014. View at Publisher · View at Google Scholar
  12. H. Gensicke, S. M. Zinkstok, Y. B. Roos et al., “IV thrombolysis and renal function,” Neurology, vol. 81, no. 20, pp. 1780–1788, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Naganuma, M. Koga, Y. Shiokawa et al., “Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry,” Cerebrovascular Diseases, vol. 31, no. 2, pp. 123–129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Ovbiagele, E. E. Smith, L. H. Schwamm et al., “Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke,” Circulation: Cardiovascular Quality and Outcomes, vol. 7, no. 6, pp. 929–935, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zhang, L. Churilov, A. Meretoja, S. Teo, S. M. Davis, and B. Yan, “Elevated urea level is associated with poor clinical outcome and increased mortality post intravenous tissue plasminogen activator in stroke patients,” Journal of the Neurological Sciences, vol. 332, no. 1-2, pp. 110–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. B. Marsh, R. F. Gottesman, A. E. Hillis, V. C. Urrutia, and R. H. Llinas, “Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IVtPA),” Medicine (Baltimore), vol. 92, no. 6, pp. 317–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Hao, C. Yang, M. Liu, and B. Wu, “Renal dysfunction and thrombolytic therapy in patients with acute ischemic stroke: a systematic review and meta-analysis,” Medicine, vol. 93, no. 28, article e286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Undas, A. Slowik, P. Wolkow, A. Szczudlik, and W. Tracz, “Fibrin clot properties in acute ischemic stroke: relation to neurological deficit,” Thrombosis Research, vol. 125, no. 4, pp. 357–361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Sjøland, J. J. Sidelmann, M. Brabrand et al., “Fibrin clot structure in patients with end-stage renal disease,” Thrombosis and Haemostasis, vol. 98, no. 2, pp. 339–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-H. Chen, S.-C. Tang, L.-K. Tsai et al., “Proteinuria independently predicts unfavorable outcome of ischemic stroke patients receiving intravenous thrombolysis,” PLoS ONE, vol. 8, no. 11, Article ID e80527, 2013. View at Publisher · View at Google Scholar · View at Scopus